LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.79 | 17.25 | 9963 | 6008 | 1.6582 | 1.1234 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.79 | 17.25 | 7 | 6008 | 0.0012 | -0.1013 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 86.79 | 17.25 | 10577 | 6008 | 1.7604 | 1.1385 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 88.76 | 17.25 | 43 | 6047 | 0.0071 | 0.1141 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 88.76 | 17.25 | 10327 | 6047 | 1.7075 | 1.1307 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 88.76 | 17.25 | 9 | 6047 | 0.0015 | -0.0741 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 88.76 | 17.25 | 10960 | 6047 | 1.8122 | 1.1457 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 90.74 | 17.25 | 47 | 6109 | 0.0077 | 0.1256 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 90.74 | 17.25 | 10564 | 6109 | 1.7291 | 1.1336 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 90.74 | 17.25 | 7 | 6109 | 0.0011 | -0.1010 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 90.74 | 17.25 | 11319 | 6109 | 1.8527 | 1.1511 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.71 | 17.25 | 38 | 6184 | 0.0061 | 0.0975 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.71 | 17.25 | 10930 | 6184 | 1.7674 | 1.1388 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.71 | 17.25 | 4 | 6184 | 0.0006 | -0.1582 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 92.71 | 17.25 | 11571 | 6184 | 1.8711 | 1.1533 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 17.25 | 11 | 6239 | 0.0018 | -0.0516 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 17.25 | 11173 | 6239 | 1.7907 | 1.1419 | MN20160310_N02 | H17 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 17.25 | 5 | 6239 | 0.0008 | -0.1356 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.031623 | 94.68 | 17.25 | 11938 | 6239 | 1.9134 | 1.1587 | MN20160310_N02 | I20 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.06 | 17.25 | 638 | 143 | 4.4549 | 2.2623 | MN20160310_N02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.06 | 17.25 | 1 | 143 | 0.0070 | -0.6065 | MN20160310_N02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 3.06 | 17.25 | 245 | 143 | 1.7107 | 1.3845 | MN20160310_N02 | H18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 5.03 | 17.25 | 1 | 273 | 0.0037 | -0.5106 | MN20160310_N02 | C03 |
| MCF 10A-H2B-mCherry | Neratinib | 0.056234 | 5.03 | 17.25 | 816 | 273 | 2.9851 | 1.6314 | MN20160310_N02 | C03 |